Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05424380 |
| Title | A Phase 1, Open Label Study of Intravenous GSK3745417 to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Determine RP2D & Schedule in Participants With Relapsed or Refractory Myeloid Malignancies Including AML and HR MDS |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | GlaxoSmithKline |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | NLD | ITA | ESP | DEU | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Toronto | Ontario | M5G 2M9 | Canada | Details | |
| GSK Investigational Site | Dresden | Sachsen | 01307 | Germany | Details | |
| GSK Investigational Site | Leipzig | Sachsen | 04103 | Germany | Details | |
| GSK Investigational Site | Meldola | 47014 | Italy | Details | ||
| GSK Investigational Site | Perugia | 06132 | Italy | Details | ||
| GSK Investigational Site | Roma | 00168 | Italy | Details | ||
| GSK Investigational Site | Rotterdam | 3015 GD | Netherlands | Details | ||
| GSK Investigational Site | Madrid | 28033 | Spain | Details | ||
| GSK Investigational Site | Madrid | 28040 | Spain | Details | ||
| GSK Investigational Site | Valencia | 46026 | Spain | Details |